These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 30306811)
21. Pharmacokinetics of Ambroxol Sustained Release (Mucosolvan Ollier C; Sent U; Mesquita M; Michel MC Pulm Ther; 2020 Jun; 6(1):119-130. PubMed ID: 32372294 [TBL] [Abstract][Full Text] [Related]
22. Pharmacobezoar Associated Prolonged Clinical Course in a Patient with Immediate Release Quetiapine Overdose. Inoue F; Okazaki Y; Huh K; Ichiba T; Chiba T; Namera A J Med Toxicol; 2024 Aug; ():. PubMed ID: 39093496 [TBL] [Abstract][Full Text] [Related]
23. Self-assembled polyelectrolyte complexes films as efficient compression coating layers for controlled-releasing tablets. Li W; Huo M; Sen Chaudhuri A; Yang C; Cao D; Wu Z; Qi X J Mater Sci Mater Med; 2017 May; 28(5):67. PubMed ID: 28337667 [TBL] [Abstract][Full Text] [Related]
24. Extended-release quetiapine overdose is associated with delayed onset of toxicity compared to immediate-release quetiapine overdose. Taylor L; Graudins A Emerg Med Australas; 2019 Aug; 31(4):562-568. PubMed ID: 30485698 [TBL] [Abstract][Full Text] [Related]
25. Endoscopic removal of slow release clomipramine bezoars in two cases of acute poisoning. Höjer J; Personne M Clin Toxicol (Phila); 2008 Apr; 46(4):317-9. PubMed ID: 18363128 [TBL] [Abstract][Full Text] [Related]
26. Formulation, release characteristics, and bioavailability study of gastroretentive floating matrix tablet and floating raft system of Mebeverine HCl. El Nabarawi MA; Teaima MH; Abd El-Monem RA; El Nabarawy NA; Gaber DA Drug Des Devel Ther; 2017; 11():1081-1093. PubMed ID: 28435220 [TBL] [Abstract][Full Text] [Related]
27. Clinical and Forensic Aspects of Pharmacobezoars. Basílio F; Dinis-Oliveira RJ Curr Drug Res Rev; 2020; 12(2):118-130. PubMed ID: 32065097 [TBL] [Abstract][Full Text] [Related]
28. Evaluation of hydrophilic matrix tablets based on Carbopol(®) 971P and low-viscosity sodium alginate for pH-independent controlled drug release. Al-Zoubi NM; AlKhatib HS; Obeidat WM Drug Dev Ind Pharm; 2011 Jul; 37(7):798-808. PubMed ID: 21247372 [TBL] [Abstract][Full Text] [Related]
29. Endoscopic removal of pharmacobezoar in case of intentional potassium overdose. Briggs AL; Deal LL J Emerg Med; 2014 Mar; 46(3):351-4. PubMed ID: 24113476 [TBL] [Abstract][Full Text] [Related]
30. Floating tablets for controlled release of ofloxacin via compression coating of hydroxypropyl cellulose combined with effervescent agent. Qi X; Chen H; Rui Y; Yang F; Ma N; Wu Z Int J Pharm; 2015 Jul; 489(1-2):210-7. PubMed ID: 25956047 [TBL] [Abstract][Full Text] [Related]
31. Prediction of the Oral Pharmacokinetics and Food Effects of Gabapentin Enacarbil Extended-Release Tablets Using Biorelevant Dissolution Tests. Yamaguchi Ikeuchi S; Kambayashi A; Kojima H; Oku N; Asai T Biol Pharm Bull; 2018; 41(11):1708-1715. PubMed ID: 30381671 [TBL] [Abstract][Full Text] [Related]
32. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen. Cao QR; Choi YW; Cui JH; Lee BJ J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656 [TBL] [Abstract][Full Text] [Related]
34. Film-coated matrix mini-tablets for the extended release of a water-soluble drug. Mohamed FA; Roberts M; Seton L; Ford JL; Levina M; Rajabi-Siahboomi AR Drug Dev Ind Pharm; 2015 Apr; 41(4):623-30. PubMed ID: 24564797 [TBL] [Abstract][Full Text] [Related]
35. Retrospective analysis of the biopharmaceutics characteristics of solid oral Modified-Release drug products in approved US FDA NDAs designated as Extended-Release or Delayed-Release formulations. Ahmed N; Ly H; Pan A; Chiang B; Raines K; Janwatin T; Hamed S; Dave K Eur J Pharm Biopharm; 2023 Dec; 193():294-305. PubMed ID: 37984592 [TBL] [Abstract][Full Text] [Related]
36. Halloysite nanotubes-cellulose ether based biocomposite matrix, a potential sustained release system for BCS class I drug verapamil hydrochloride: Compression characterization, in-vitro release kinetics, and in-vivo mechanistic physiologically based pharmacokinetic modeling studies. Husain T; Shoaib MH; Ahmed FR; Yousuf RI; Siddiqui F; Saleem MT; Farooqi S; Jabeen S Int J Biol Macromol; 2023 Nov; 251():126409. PubMed ID: 37598820 [TBL] [Abstract][Full Text] [Related]
37. Preparation and evaluation of verapamil hydrochloride microcapsules. Mukherjee B; Mahanti B; Panda P; Mahapatra S Am J Ther; 2005; 12(5):417-24. PubMed ID: 16148427 [TBL] [Abstract][Full Text] [Related]
38. Optimization and evaluation of modified release solid dosage forms using artificial neural network. Sheth TS; Acharya F Sci Rep; 2024 Jul; 14(1):16358. PubMed ID: 39014107 [TBL] [Abstract][Full Text] [Related]
39. Correlation between the viscoelastic properties of the gel layer of swollen HPMC matrix tablets and their in vitro drug release. Hamed R; Al Baraghthi T; Sunoqrot S Pharm Dev Technol; 2018 Nov; 23(9):838-848. PubMed ID: 27808590 [TBL] [Abstract][Full Text] [Related]